Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 Par Value
-
Shares outstanding
-
117M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
57.8K
-
Shares change
-
+25.5K
-
Total reported value, excl. options
-
$340K
-
Value change
-
+$150K
-
Number of buys
-
2
-
Price
-
$5.88
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) as of Q4 2023
2 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value as of Q4 2023.
Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.8K shares
of 117M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.76M shares), Kynam Capital Management, LP (5.85M shares), TCG Crossover Management, LLC (5.63M shares), COMMODORE CAPITAL LP (5.57M shares), FMR LLC (5.3M shares), Point72 Asset Management, L.P. (5.19M shares), VR Adviser, LLC (4.68M shares), VANGUARD GROUP INC (4.53M shares), STATE STREET CORP (4.15M shares), and SUVRETTA CAPITAL MANAGEMENT, LLC (3.71M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.